Pierre Joffrin

Pierre is an Associate Partner of Syncona Investment Management Ltd.

Pierre has a diverse experience in both biotech company building and venture investment, starting out at OSE and most recently as a Senior Associate at Jeito. Previously he was the first employee and served as the Corporate Development Officer at Mogrify, a Cell and Gene therapy company in Cambridge, where he led pipeline strategy, BD and IR. Pierre originally trained in Biochemistry at the University of St Andrews and Pharmacology at the university of Oxford where he conducted research on breast cancer biomarkers development for radiotherapy.